47 results on '"Boninsegna, S"'
Search Results
2. Antiviral Therapy for Hepatitis C Virus Recurrence Following Liver Transplantation: Long-Term Results From a Single Center Experience
3. Encapsulation of individual pancreatic islets by sol–gel SiO 2: : A novel procedure for perspective cellular grafts
4. P4.30: Endothelial Dysfunction and Cardiovascular Risk Profile in Patients with Chronic Hepatitis C Virus Infection
5. HCV Histological Recurrence and Survival Following Liver Transplantation in Patients With and Without Hepatocellular Carcinoma
6. Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study
7. Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B
8. FIBROSIS PROGRESSION AFTER ANTIVIRAL TREATMENT (AT) FOR HCV RECURRENCE FOLLOWING LIVER TRANSPLANTATION
9. The Benefit of Antiviral Therapy On Fibrosis Progression Due To Hcv Recurrence After Liver Transplantation (lt): An Italian Multicenter Study
10. GENOTYPE 2 AND 3 RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION: EXCELLENT RESULTS WITH SUBOPTIMAL DOSES OF ANTIVIRAL THERAPY
11. A randomized study comparing 48 and 96 weeks peginterferon alfa-2a therapy in genotype D HBeAg negative chronic hepatitis B
12. Evolving clinical landscape of chronic hepatitis B: A multicenter Italian Study
13. Evaluation of compliance in patients before and after liver transplantation (LT)
14. Evaluation of compliance in patients with chronic liver disease
15. SiO2 entrapment of animal cells. Part II. Protein diffusion through collagen membranes coated with sol-gel SiO2
16. Endothelial dysfunction and cardiovascular risk profile in patients with chronic hepatitis C virus infection
17. Encapsulation of individual pancreatic islets by sol–gel SiO2:: A novel procedure for perspective cellular grafts
18. Rapid detection of a protein C gene mutation present in the asymptomatic and not in the thrombosis-prone lineage.
19. A recurrent missense mutation (Arg → Gln) and a partial deletion in factor VIII gene causing severe haemophilia A.
20. Genotypes 2 and 3 recurrent hepatitis C after liver transplantation: Excellent results with suboptimal doses of antiviral therapy
21. Histological HCV recurrence after liver transplantation (LT): The impact of antiviral therapy on fibrosis progression
22. PA.191 COMBINED ANTIVIRAL THERAPY(PEG-IFN +RIBAVIRINE) IN RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION. AN ITALIAN EXPERIENCE OF TWO TRANSPLANT CENTRES
23. 208 Evaluation of compliance in patients with chronic liver disease
24. 131 Female HCV cirrhosis liver transplant recipients have worse fibrosis progression due to recurrent hcv than male HCV recipients
25. RFLP and gene lesions in disorders of hemostasis
26. A RECURRENT AMINOACID SUBSTITUTION AND A PARTIAL GENE DELETION IN SEVERE HEMOPHILIA A
27. Predictive factors of HCV recurrence after liver transplantation (OLTX)
28. 682 INNATE IMMUNE SYSTEM RESPONSES DIFFER DURING RECENT AND CHRONIC HEPATITIS C VIRUS INFECTION
29. 132 ALLOGRAFT EXPRESSION OF INNATE IMMUNITY GENES INFLUENCES LIVER FIBROSIS PROGRESSION AND ACUTE CELLULAR REJECTION IN LIVER TRANSPLANTED PATIENTS
30. 28 ALLOGRAFT EXPRESSION OF INNATE IMMUNITY GENES INFLUENCES LIVER FIBROSIS PROGRESSION AND ACUTE CELLULAR REJECTION IN LIVER TRANSPLANTED PATIENTS.
31. SiO2 Entrapment of animal cells. Part 2: Protein diffusion through collagen membranes coated with sol–gel SiO2.
32. Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C
33. 524 RESPONSE-GUIDED PEGINTERFERON ALFA-2A THERAPY BASED ON HBSAG LEVELS AT WEEK 12 AND WEEK 24 OR 48 IMPROVES RESPONSE RATES IN HBEAG-NEGATIVE, GENOTYPE D PATIENTS
34. 98 EXTENDED (2 YEARS) TREATMENT WITH PEGINTERFERON ALFA-2A [40KD] IMPROVES SUSTAINED RESPONSE RATES IN GENOTYPE D PATIENTS WITH HBEAG NEGATIVE CHRONIC HEPATITIS B
35. Epstein-Barr Virus (EBV) acute acalculous cholecystitis in an immunocompromised adult patient: a case report and a literature review of a neglected clinical presentation.
36. Antiviral activity of bone morphogenetic proteins and activins.
37. Impact of IL-27 on hepatocyte antiviral gene expression and function.
38. Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B.
39. Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C.
40. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
41. HLA-DRB1 donor-recipient mismatch affects the outcome of hepatitis C disease recurrence after liver transplantation.
42. Fatal hepatic decompensation in a bone marrow transplant recipient with HBV-related cirrhosis following lamivudine withdrawal.
43. SiO(2) entrapment of animal cells: liver-specific metabolic activities in silicaoOverlaid hepatocytes.
44. Nuclear accumulation of c-myc mRNA in phytohaemagglutinin-activated T lymphocytes treated with anti-HLA class I monoclonal antibody.
45. Identification of a novel protein kinase C inhibitor in microsomes from phytohaemagglutinin activated human peripheral blood mononuclear cells.
46. Anchored anti-HLA class I monoclonal antibody fails to induce inhibition of PHA-activated lymphocytes proliferation.
47. A recurrent missense mutation (Arg----Gln) and a partial deletion in factor VIII gene causing severe haemophilia A.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.